ArticleCochrane evidence synthesis and methods2025
Using GPT-4 for Title and Abstract Screening in a Literature Review of Public Policies: A Feasibility Study.
Article in Cochrane evidence synthesis and methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genetic susceptibility of Alzheimer's disease associated with APOE polymorphism: systematic review and bibliometric study.Journal, genetic engineering & biotechnology · 2026Review
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: We describe the first known use of large language models (LLMs) to screen titles and abstracts in a review of public policy literature. Our objective was to assess the percentage of articles GPT-4 recommended for exclusion that should have been included ("false exclusion rate"). Methods: We used GPT-4 to exclude articles from a database for a literature review of quantitative evaluations of federal and state policies addressing the opioid crisis. We exported our bibliographic database to a CSV file containing titles, abstracts, and keywords and asked GPT-4 to recommend whether to exclude each article. We conducted a preliminary testing of these recommendations using a subset of articles and a final test on a sample of the entire database. We designated a false exclusion rate of 10% as an adequate performance threshold. Results: GPT-4 recommended excluding 41,742 of the 43,480 articles (96%) containing an abstract. Our preliminary test identified only one false exclusion; our final test identified no false exclusions, yielding an estimated false exclusion rate of 0.00 [0.00, 0.05]. Fewer than 1%-417 of the 41,742 articles-were incorrectly excluded. After manually assessing the eligibility of all remaining articles, we identified 608 of the 1738 articles that GPT-4 did not exclude: 65% of the articles recommended for inclusion should have been excluded. Discussion/Conclusions: GPT-4 performed well at recommending articles to exclude from our literature review, resulting in substantial time and cost savings. A key limitation is that we did not use GPT-4 to determine inclusions, nor did our model perform well on this task. However, GPT-4 dramatically reduced the number of articles requiring review. Systematic reviewers should conduct performance evaluations to ensure that an LLM meets a minimally acceptable quality standard before relying on its recommendations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.